Dr. Bharat Kwatra Comp. Precision Oncology
Industry & research

Building the next generation of oncology

Precision oncology increasingly requires collaboration across molecular diagnostics, clinical medicine, computation, evidence generation and technology.

Who this is for

Partners

Nine kinds of organisation, each usually arriving with a different problem.

PharmaceuticalBiotechnologyDiagnosticsContract Research OrganisationsTrial SponsorsAI & TechnologyHospitalsUniversitiesResearch Institutions
Engagement models

Four ways to work together

01

Advisory

Scientific and clinical precision-oncology advisory work: reviewing programme design, assessing molecular strategy, and providing an independent read on scientific direction.

02

Research

Joint research, translational research, investigator-initiated studies and biomarker programmes, with defined scientific leadership and data governance.

03

Clinical

Trial feasibility, patient identification strategy, biomarker strategy, clinical pathway design and molecular tumour board implementation.

04

Technology

Artificial intelligence, natural language processing, clinical intelligence, molecular interpretation, trial matching and clinical decision support.

For researchers

Academic and research collaboration

Collaboration with universities and research institutions is handled separately from commercial engagement, with different expectations around publication, authorship and data governance.

Discuss

Start a conversation

Commercial and academic enquiries are routed separately. Terms, intellectual property and publication rights are agreed in writing before work begins.

Book a consultation

Talk it through before you decide

Monday to Saturday, 12:00 – 18:00 · by appointment at KPCIRC, Paschim Vihar. Remote review available for patients and clinicians elsewhere.

WhatsApp